P. Read

发表

SMS reminders improve re-screening in women and heterosexual men with chlamydia infection at Sydney Sexual Health Centre: a before-and-after study

R. Guy, H. Wand, V. Knight, 2012, Sexually Transmitted Infections.

Evaluation of knowledge and utility of the 2014 Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men among general practitioners in Sydney.

P. Read, D. Templeton, P. C. G. Adam, 2017, Sexual health.

Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system.

P. Read, L. Degenhardt, J. Grebely, 2021, Drug and alcohol dependence.

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.

M. Alavi, P. Read, A. Milat, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

P. Read, B. Conway, M. Hellard, 2018, The lancet. Gastroenterology & hepatology.

Missed opportunities for HIV testing--a costly oversight.

P. Read, D. Armstrong-James, C. Tong, 2011, QJM : monthly journal of the Association of Physicians.

Increased Syphilis Testing of Men Who Have Sex With Men: Greater Detection of Asymptomatic Early Syphilis and Relative Reduction in Secondary Syphilis

David Bruce Lewis, J. Kaldor, M. O’Sullivan, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection.

P. Read, M. Hellard, J. Rockstroh, 2021, Journal of hepatology.

One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.

P. Read, A. McNulty, Monica Lahra, 2013, Sexual health.

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.

C. Stedman, P. Read, B. Conway, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sensitivity of 20-Minute Voiding Intervals in Men Testing for Chlamydia trachomatis

V. Knight, Aurelie Kenigsberg, P. Read, 2012, Sexually transmitted diseases.

Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort

P. Read, M. Hellard, G. Dore, 2022, Health science reports.

Fast-Track Services for All? The Preferences of Chinese-, Korean-, and Thai-Speaking Women Attending a Sexual Health Service

V. Knight, P. Read, A. McNulty, 2013, Sexually transmitted diseases.

Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence.

P. Read, D. Templeton, R. Varma, 2014, Sexual health.

Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.

P. Read, Catherine Kostovski, M. Harrod, 2019, Sexual health.

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.

P. Read, G. Dore, I. van Beek, 2017, The International journal on drug policy.

Contact tracing using provider referral: how difficult is it?

P. Read, A. McNulty, Warwick Allan, 2013, Sexual health.

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

D. Cooper, R. Guy, P. Read, 2018, The lancet. HIV.

Unprotected fellatio between female sex workers and their clients in Sydney, Australia

R. Guy, H. Wand, P. Read, 2012, Sexually Transmitted Infections.

Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.

P. Read, G. Dore, A. Balcomb, 2021, The International journal on drug policy.

Client Feedback and Satisfaction With an Express Sexually Transmissible Infection Screening Service at an Inner-City Sexual Health Center

V. Knight, P. Read, A. McNulty, 2013, Sexually transmitted diseases.

Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays.

D. E. Smith, R. Guy, P. Read, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

P. Read, G. Dore, J. Grebely, 2022, Viruses.

Treatment adherence and support for people who inject drugs taking direct‐acting antiviral therapy for hepatitis C infection

P. Read, G. Dore, R. Gilliver, 2019, Journal of viral hepatitis.

High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study.

Stephen T. Wright, P. Read, M. Law, 2014, Sexual health.

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study

M. Alavi, P. Read, A. Milat, 2022, Viruses.

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study

P. Read, G. Dore, M. Weltman, 2019, Journal of viral hepatitis.

Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort

Jessica R. Ackerman, P. Read, G. Dore, 2022, Journal of viral hepatitis.

Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study.

P. Read, M. Hellard, G. Dore, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.

P. Read, M. Hellard, G. Dore, 2020, AIDS.

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial

P. Read, G. Dore, M. Weltman, 2020, Health science reports.

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis.

P. Read, G. Dore, P. Vickerman, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study

P. Read, G. Dore, C. Treloar, 2019, Journal of viral hepatitis.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.

P. Read, B. Conway, M. Hellard, 2018, The International journal on drug policy.

Increasing trends of syphilis among men who have sex with men in high income countries.

P. Read, C. Fairley, E. Chow, 2015, Sexual health.

Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.

David Bruce Lewis, R. Guy, P. Read, 2021, The lancet. HIV.

Treatment and outcomes of polymerase chain reaction-confirmed early syphilis.

R. Guy, P. Read, B. Donovan, 2015, Sexual Health.

Community event-based outreach screening for syphilis and other sexually transmissible infections among gay men in Sydney, Australia.

R. Guy, V. Knight, P. Read, 2013, Sexual Health.

Does Living Outside of a Major City Impact on the Timeliness of Chlamydia Treatment? A Multicenter Cross-Sectional Analysis

R. Guy, V. Knight, P. Read, 2016, Sexually transmitted diseases.

Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia.

P. Read, A. McNulty, D. Templeton, 2021, AIDS.

The rise of targeted HIV oral rapid testing in Australia

P. Read, D. Chan, R. Finlayson, 2015, The Medical journal of Australia.

Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome

P. Read, A. McNulty, 2013, The Medical journal of Australia.

Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019

P. Read, A. McNulty, M. Hellard, 2023, The Medical journal of Australia.

Is azithromycin adequate treatment for asymptomatic rectal chlamydia?

R. Guy, H. Wand, P. Read, 2011, International journal of STD & AIDS.

Azithromycin-Resistant Syphilis-Causing Strains in Sydney, Australia: Prevalence and Risk Factors

R. Guy, P. Read, G. Gilbert, 2014, Journal of Clinical Microbiology.

The prevalence of Trichomonas vaginalis detected by wet mount and polymerase chain reaction in Sydney women.

P. Read, A. McNulty, Ivy Kwon, 2013, Sexual health.

Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests

J. Kaldor, S. Garland, R. Guy, 2014, BMC Infectious Diseases.

A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics

R. Guy, P. Read, A. McNulty, 2016, Sexually Transmitted Infections.

Treponema pallidum Strain Types and Association with Macrolide Resistance in Sydney, Australia: New TP0548 Gene Types Identified

R. Guy, P. Read, G. Gilbert, 2016, Journal of Clinical Microbiology.

Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men

R. Guy, V. Knight, P. Read, 2021, HIV medicine.

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

P. Read, G. Dore, A. Balcomb, 2021, Hepatology communications.

Do callers to the NSW Sexual Health Infoline attend the services they are referred to?

V. Knight, P. Read, A. McNulty, 2013, Sexual health.

Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.

M. Alavi, P. Read, G. Dore, 2022, The International journal on drug policy.

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.

M. Alavi, P. Read, A. Milat, 2022, The International journal on drug policy.

Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs.

C. Stedman, P. Read, B. Conway, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations.

J. Kaldor, S. Garland, R. Guy, 2015, American journal of preventive medicine.

Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.

P. Read, G. Dore, J. Grebely, 2023, The International journal on drug policy.

The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial

J. Kaldor, R. Guy, H. Wand, 2015, BMC Public Health.

Preparing for a syndemic: incorporating opioid overdose management into routine care for people who inject drugs initiating hepatitis C treatment

P. Read, R. Gilliver, J. Kearley, 2020, Internal medicine journal.

Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study

P. Read, B. Conway, M. Hellard, 2017 .

Clients' preferred methods of obtaining sexually transmissable infection or HIV results from Sydney Sexual Health Centre.

V. Knight, P. Read, A. McNulty, 2013, Sexual health.

Would you self-collect swabs in a unisex toilet?

P. Read, A. McNulty, Lynne Martin, 2012, Sexual health.

Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low‐threshold primary health‐care opioid agonist treatment program

P. Read, R. Gilliver, K. Chronister, 2019, Drug and alcohol review.

Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.

P. Read, G. Dore, L. Degenhardt, 2023, Drug and alcohol review.

Clinical aspects of adult syphilis

P. Read, B. Donovan, P. J. Read, 2012, Internal medicine journal.

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

N. Luhmann, J. Lazarus, P. Read, 2019, Journal of internal medicine.

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.

P. Read, G. Dore, I. van Beek, 2017, The International journal on drug policy.

Raltegravir‐emtricitabine‐tenofovir as HIV nonoccupational post‐exposure prophylaxis in men who have sex with men: safety, tolerability and adherence

P. Read, A. McNulty, A. Carr, 2014, HIV medicine.